机构:[1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.[2]Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.[3]Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.[4]Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.华中科技大学同济医学院附属协和医院
National Natural Science Foundation of China (81770707); the Guangdong
Natural Science Funds for Distinguished Young Scholar (No. 2018B030306027).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区综合性期刊
小类|2 区综合性期刊
最新[2025]版:
大类|2 区综合性期刊
小类|2 区综合性期刊
第一作者:
第一作者机构:[1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Yuting,Zhu Qing,Tao Yufeng,et al.Renal lysophospholipase A1 contributes to Enterococcus faecalis-induced hypertension by enhancing sodium reabsorption[J].iScience.2022,25(12):105403.doi:10.1016/j.isci.2022.105403.
APA:
Liu Yuting,Zhu Qing,Tao Yufeng,Zeng Yuting,Li Shasha...&Wang Lei.(2022).Renal lysophospholipase A1 contributes to Enterococcus faecalis-induced hypertension by enhancing sodium reabsorption.iScience,25,(12)
MLA:
Liu Yuting,et al."Renal lysophospholipase A1 contributes to Enterococcus faecalis-induced hypertension by enhancing sodium reabsorption".iScience 25..12(2022):105403